BEIJING - An unprecedented anti-corruption crackdown is sweeping through China’s healthcare industry, causing anxiety among hospitals, pharmaceutical companies and other segments of an industry that is vital to the well-being of 1.4 billion Chinese people.
As of Aug 9, more than 150 hospital chiefs nationwide were placed under investigation this year. That is twice the number from the previous year, based on government reports.
Already a subscriber? Log in
Read the full story and more at $9.90/month
Get exclusive reports and insights with more than 500 subscriber-only articles every month
ST One Digital
$9.90/month
No contract
ST app access on 1 mobile device
Unlock these benefits
All subscriber-only content on ST app and straitstimes.com
Easy access any time via ST app on 1 mobile device
E-paper with 2-week archive so you won't miss out on content that matters to you
